Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis [Phase 3]
Extension study assessing long-term safety of BIBF 1120 (nintedanib) in idiopathic pulmonary fibrosis after completion of prior trials.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: A Validation and Dosimetry Study of GSK2634673F PET Ligand [Phase 1]
Phase 1 study evaluating the GSK2634673F PET ligand for validation and dosimetry in idiopathic pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 4]
Phase 4 safety and tolerability trial evaluating the combination of pirfenidone and nintedanib in idiopathic pulmonary fibrosis. The study h…
-
CLINICAL_TRIALS research · 2018-06-07Clinical Trial Update: Feasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
This entry reports a Phase 2 feasibility and effect study of a tele-rehabilitation program for idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients [Phase 1]
Phase 1 trial update evaluating inhaled therapy for idiopathic pulmonary fibrosis has completed, sponsored by GlaxoSmithKline.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 trial evaluated autologous mesenchymal stem cells for idiopathic pulmonary fibrosis and has completed.
-
CLINICAL_TRIALS withdrawal · 2018-05-01Clinical Trial Update: Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil [Phase 4]
Phase 4 trial evaluating sildenafil for pulmonary hypertension associated with idiopathic pulmonary fibrosis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
Phase 3 trial results comparing nintedanib taken twice daily to placebo in idiopathic pulmonary fibrosis were posted in 2018.
-
CLINICAL_TRIALS withdrawal · 2018-03-06Clinical Trial Update: Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan [Phase 4]
A Phase 4 study investigating bosentan for pulmonary arterial hypertension secondary to idiopathic pulmonary fibrosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF [Phase 4]
Phase 4 trial update assessing safety, tolerability, and pharmacokinetics of nintedanib in combination with pirfenidone in idiopathic pulmon…
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations [Phase 1, Phase 2]
Phase 1/2 trial update evaluating the combination of plasma exchange, rituximab, and steroids for acute exacerbations of idiopathic pulmonar…
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of allogeneic mesenchymal stem cells in rapidly progressive interstitial lung disease, comple…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 pilot trial evaluating omeprazole for idiopathic pulmonary fibrosis has completed. The study was sponsored by Newcastle-upon-Tyne …
-
CLINICAL_TRIALS research · 2017-11-17Clinical Trial Update: Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada
This observational study evaluates disease course and outcomes in Canadian patients with idiopathic pulmonary fibrosis treated with pirfenid…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole [Phase 3]
Phase 3 trial evaluating cotrimoxazole for idiopathic pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis
A completed clinical trial update reports on the responsiveness and minimally important difference of the 4-meter gait speed test in idiopat…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: The Predictive Ability of 4MGS in IPF
The document reports on a completed clinical trial assessing how well four-meter gait speed (4MGS) predicts outcomes in idiopathic pulmonary…
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis [Phase 1]
This clinical trial update reports completion of a Phase 1 study evaluating the combination of oral vismodegib with pirfenidone in participa…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
A completed clinical trial from the University of Michigan evaluating biomarker profiles in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS research · 2017-07-12Clinical Trial Update: Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary Fibrosis
This clinical trial update reports on the prevalence of airway disease among patients with idiopathic pulmonary fibrosis and its impact on p…
-
CLINICAL_TRIALS research · 2017-06-15Clinical Trial Update: Role of Stem Cell Therapy in Interstitial Pulmonary Fibrosis [Phase 1]
Phase 1 trial exploring stem cell therapy for idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial update evaluating inhaled carbon monoxide as a treatment for idiopathic pulmonary fibrosis, with the study completed …
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis [NA]
Clinical trial update focusing on characteristics and health-related quality of life in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide [Phase 3]
Phase 3 trial evaluating thalidomide for chronic cough in idiopathic pulmonary fibrosis completed, with results posted in May 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 randomized dose-ranging study evaluated the efficacy of tralokinumab in adults with idiopathic pulmonary fibrosis; the trial was t…